Jennifer Huff
Nurse Practitioner · Knoxville, TNNPI 1649696949
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $878 and has fallen 82.7% since, to $152 in 2025.
Across 61 payments — averaging $31.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$242
- Novartis$176
- Incyte Corporation$157
- Johnson & Johnson$138
- Exelixis Inc.$122
- Puma Biotechnology, Inc.$113
- plus $997 from 21 others
What the payments were for
- Food & beverage$1,944100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $242 |
| Novartis | 8 | $176 |
| Incyte Corporation | 3 | $157 |
| Johnson & Johnson | 4 | $138 |
| Exelixis Inc. | 1 | $122 |
| Puma Biotechnology, Inc. | 2 | $113 |
| Genentech USA, Inc. | 1 | $98 |
| E.r. Squibb & Sons, L.L.C. | 3 | $97 |
| GSK | 2 | $89 |
| Tempus AI, Inc | 1 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Dendreon Pharmaceuticals LLC | 2 | $68 |
| Amgen | 4 | $67 |
| Merck | 3 | $60 |
| Novo Nordisk | 1 | $59 |
| Gilead | 1 | $59 |
| Seagen Inc. | 3 | $43 |
| Bristol Myers Squibb | 2 | $35 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Acceleron Pharma, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Bayer | 1 | $19 |
| Sanofi | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,944 in reported general payments places this provider in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Knoxville
- Karen RodenKnoxville$265K
- Erica HembreeKnoxville$125K
- Robin LovedayKnoxville$56K
- Tiffany SteelmanKnoxville$21K
- Jennifer BerryKnoxville$19K
- Erica HillKnoxville$13K
- Amy HatcherMurfreesboro$1.1M
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Brooke FaughtNashville$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.